Clinical Trial

Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome

Name: Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome — clinical trial record (NCT07743242)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

AIHA is a heterogeneous autoimmune cytopenia with variable severity and significant morbidity. APS is defined by thrombosis and/or obstetric morbidity with persistent antiphospholipid antibodies (aPL).

Trial Details

NCT Number	NCT07743242
Lead Sponsor	New Valley University
Conditions	Anti Phospholipid Syndrome
Enrollment	230 participants
Start Date	2026-06-05
Primary Completion	2027-11-30 (estimated)
Study Completion	2028-04-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-10